Summary
In the isolated rat vas deferens stimulated at 0.2 Hz, a series of 2′, 3′-, and 5′-substituted adenine nucleotides all inhibited the twitch responses, their actions being potentiated by the nucleoside transport inhibitors, HNBTGR, NBMPR and dipyridamole.
The metabolism of these nucleotides was examined utilising HPLC analysis of the bathing medium after exposure to 30 μM nucleoside or nucleotide for 5 min. 5′-AMP, 5′-ADP, 5′-ATP, and NAD+ were all partially hydrolysed to adenosine, the relative extent of this being 5′-AMP>5′-ADP=5′-ATP≫NAD+. However, the other nucleotides examined were not detectably converted to adenosine or to adenosine deamination products.
These results indicate that the 2′-, 3′- and 5′-substituted nucleotides studied act at a P1-purinoceptor in rat vas deferens to inhibit neurotransmission and, with the exception of 5′-AMP, 5′-ADP, 5′-ATP and NAD+, all appear to act directly at this receptor. However, the 5′-adenine nucleotides (AMP, ADP and ATP) and NAD+ all appear to act at least partially indirectly subsequent to their hydrolysis to adenosine.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- ADA:
-
adenosine deaminase (EC 3.5.4.4)
- 5′-ADP:
-
adenosine 5′-diphosphate
- 2′,5′-ADP:
-
adenosine 2′,5′-diphosphate
- 3′:
-
5′-ADP, adenosine 3′,5′-diphosphate
- 2′-, 3′ or 5′-AMP:
-
adenosine 2′-, 3′-, or 5′-monophosphate
- 5′-ATP:
-
adenosine 5′-triphosphate
- cNADP+ :
-
β-nicotinamide dinucleotide 2′,3′-cyclic monophosphate
- CoA:
-
coenzyme A
- HNBTGR:
-
6-(2-hydroxy-5-nitrobenzyl)-thioguanosine
- NAD+ :
-
β-nicotinamide adenine dinucleotide
- NADP+ :
-
β-nicotinamide adenine dinucleotide phosphate
- NBMPR:
-
6-(4-nitrobenzylthio)-purine riboside
References
Baer HP, Vriend R (1984) Measurement of adenosine metabolism and uptake in smooth muscle and effects of adenosine transport inhibitors. J Pharmacol Exp Ther 229:564–570
Bruns RF (1980) Adenosine receptor activation by adenine nucleotides requires conversion of the nucleotides to adenosine. Naunyn-Schmiedeberg's Arch Pharmacol 315:5–13
Burnstock G, Hoyle CHV (1985) Actions of adenine dinucleotides in the guinea-pig taenia coli: NAD acts indirectly on P1-purinoceptors; NADP acts like a P2-purinoceptor agonist. Br J Pharmacol 84:825–831
Clanachan AS, Johns A, Paton DM (1977) Presynaptic inhibitory actions of adenine nucleotides and adenosine on neurotransmission in the rat vas deferens. Neuroscience 2:597–602
Cooke MA, Hamilton JT, Okwuasaba FK (1978) Coenzyme A is a purine nucleotide modulator of acetylcholine output. Nature 271:768–771
Harper JF (1984) Peritz' F test: Basic program of a robust multiple comparison test for statistical analysis of all differences among group means. Comput Biol Med 14:437–445
Holford NHG, MKMODEL (1985) A modelling tool for micro-computers — pharmacokinetic evaluation and comparison with standard computer programs. Clin Exptl Pharmacol Suppl 9:95
Muller MJ, Paton DM (1979) Presynaptic inhibitory actions of 2-substituted adenosine derivatives on neurotransmission on rat vs deferens: effects of inhibitory of adenosine uptake and deamination. Naunyn-Schmiedeberg's Arch Pharmacol 306: 23–28
Paton DM (1984) Classification of adenosine receptors. Meth Find Exp Clin Pharmacol 6:167–169
Paton DM, Baer HP, Clanachan AS, Lauzon PA (1978) Structure activity relations for inhibition of transmission in rat vas deferens by adenosine. Neuroscience 3:65–70
Paton DM, Webster DR (1984) Relationship of metabolism of adenine nucleotides to presynaptic inhibition of transmission in rat vas deferens. Br J Pharmacol 83:P385
Ramsey PH (1981) Power of unvariate pairwise multiple comparison procedures. Psychol Bull 90:352–366
Richards CD, Snell CE, Snell PH (1983) Nicotinamide adenine dinucleotide depresses synaptic transmission in the hippocampus and has specific binding sites on the synaptic membranes. Br J Pharmacol 79:553–564
Sawynok J, Jhamandas KH (1976) Inhibition of acetylcholine release from cholinergic nerves by adenosine, adenine nucleotides and morphine: antagonism by theophylline. J Pharmacol Exptl Ther 197:379–390
Snell CR, Snell PH, Richards CD (1984) Degradation of NAD by synaptosomes and its inhibition by nicotinamide mono-nucleotide: implications for the role of NAD as a synaptic modulator. J Neurochem 43:1610–1615
Stone TW (1981) Actions of adenine dinucleotides on the vas deferens, guinea-pig taenia caeci and bladder. Eur J Pharmacol 75:93–102
Webster DR (1985) The measurement of adenosine and adenine nucleotides in tissues and body fluids. In: Paton DM (ed) Methods in pharmacology, vol VI, Methods used in adenosine research. Plenum Publishing Corporation, New York, pp 21–42
Webster DR, Boston GD, Paton DM (1985) On the measurement of adenosine metabolites and metabolism in isolated tissue preparations. J Pharmacol Meth 13:339–350
Willemot J, Paton DM (1981a) Metabolism and presynaptic inhibitory effects of adenosine in rat vas deferens. J Auton Pharmacol 1:217–224
Willemot J, Paton DM (1981b) Metabolism and presynaptic inhibitory activity of 2′-, 3′- and 5′-adenine nucleotides in rat vas deferens. Naunyn-Schmiedeberg's Arch Pharmacol 317:110–114
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Webster, D.R., Boston, G.D., Holford, N.H.G. et al. Relationship of metabolism of 2′-, 3′- and 5′-adenine nucleotides to presynaptic inhibition of transmitter release in rat vas deferens. Naunyn-Schmiedeberg's Arch. Pharmacol. 333, 163–167 (1986). https://doi.org/10.1007/BF00506520
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00506520